Pacific Biosciences of California, Inc.
PACB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$38,000 | -$41,930 | -$426,075 | $2,371 |
| Dep. & Amort. | $4,398 | $4,579 | $372,779 | $10,945 |
| Deferred Tax | $0 | $0 | -$546 | -$205 |
| Stock-Based Comp. | $0 | $0 | $9,201 | $16,033 |
| Change in WC | $3,207 | -$3,871 | -$2,387 | $8,367 |
| Other Non-Cash | $11,688 | $11,845 | $2,972 | -$68,161 |
| Operating Cash Flow | -$18,707 | -$29,377 | -$44,056 | -$30,650 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $86 | -$550 | -$1,389 | -$1,617 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$65,825 | -$56,172 | -$61,820 | -$80,471 |
| Inv. Sales/Matur. | $84,641 | $82,005 | $113,443 | $140,326 |
| Other Inv. Act. | $0 | $0 | -$5,000 | $0 |
| Investing Cash Flow | $18,902 | $25,283 | $45,234 | $58,238 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $490 |
| Stock Issued | $1,469 | $0 | $1,959 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$50,690 |
| Financing Cash Flow | $1,469 | $0 | $1,959 | -$50,200 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,664 | -$4,094 | $3,137 | -$22,612 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $55,103 | $59,197 | $57,592 | $80,204 |
| End Cash | $56,767 | $55,103 | $60,729 | $57,592 |
| Free Cash Flow | -$18,621 | -$29,927 | -$50,445 | -$32,267 |